These facts are updated till 18 Dec 2023, and are based on Volza's Export Import data India Export data of Bevacizumab, sourced from 70 countries export import shipments with names of buyers, suppliers, top decision maker's contact information like phone, email and LinkedIn profiles.
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
30049099 | INJECTION >> INJECTION BEVACIZUMAB AVASTIN 100 MG INJECTION BEVACIZUMAB | India | Seychelles | 10 | |||
30049099 | BEVACIZUMAB >> INJ AVASTIN 100 MG BEVACIZUMAB | India | Tanzania | 20 | |||
30049099 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 100MG-4ML BATCH NO: H0153B10 , EXP DT: 12-2017 MFD DT: 12-2015 ; NO : | India | United Kingdom | 20 | |||
30049099 | SOLUTION >> BEVACIZUMAB SOLUTION BEVACIZUMAB SOLUTION PACKED IN 2 BOTTLE | India | United Kingdom | 1150 | |||
30042099 | BEVACIZUMAB >> BEVACIZUMAB 25 MG 4 ML | India | United Kingdom | 25 | 60 More Columns Available | ||
30049099 | BOTTLE >> BOTTLE BEVACIZUMAB AVASTIN 4ML BOTTLE BEVACIZUMAB 100MG-4ML | India | Yemen | 10 | |||
30049099 | SIZE >> BEVACIZUMAB INJECTION 100MG-4ML. BRAND:BEVACIREL PACK SIZE: 1 VIAL OTHER MEDCNE PUTUPFOR RETAIL SALE N.E.S ; BRAND: BEVACIREL | India | Saint Kitts And Nevis | 10 | |||
30049099 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 100MG-4ML BATCH H0190B04 EXPIRY 02-2018 MFD 02-2016 | India | United Kingdom | 1 | |||
30049099 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 400MG-16ML BATCHNO H0193B25 EXP DT.05-2018 MFD DT 06-2016 ; BATCH NO | India | United Kingdom | 6 | |||
30021500 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 100MG-4ML | India | Guyana | 2 | |||
30042099 | BEVACIZUMAB >> BEVACIZUMAB 25 MG 4 ML | India | Singapore | 25 | |||
30021500 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 400MG-4ML BEVACIREL 400MG ; BEVACIR EL | India | Philippines | 2 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 100ML-4ML BEVACIREL , BATCHNO:BMV1A17007 , MANUFACTURING DT:AUG 2017 , EXP DT:JUL 2019 N.C.V. ; BEVACIREL , BATCH NO:BMV1A17007 , MANUFACTURING | India | Vietnam | 84 | |||
30049099 | DRUG >> BEVACIZUMAB DRUG BEVACIZUMAB DRUG PRODUCT 100MG-4ML , BATCH NO. 24020011 X 0.2ML FOR LAB ANALYTICAL TESTING , NCV ; BATC H ; ANALYTICA L | India | United Kingdom | 0.20 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB REFERENCE STANDARD ACTUAL QTY.: 1 CRYO TUBE | India | Nigeria | 1 | |||
30021500 | BEVACIZUMAB >> BEVACIREL BEVACIZUMAB BEVACIREL , BEVACIZUMAB 400ML-16ML QTY:400 VIAL ; QTY: 400 | India | Vietnam | 400 | |||
30021500 | BEVACIZUMAB >> BEVACIREL BEVACIZUMAB BEVACIREL , BEVACIZUMAB 100ML-4ML QTY:84 VIAL ; QTY: 84 | India | Vietnam | 84 | |||
30049099 | DRUG >> BEVACIZUMAB DRUG BEVACIZUMAB DRUG SUBSTANCE 30.0MG-ML , BATCH NO. P24-BM-0010 X 0.2ML FOR LAB ANALYTICAL TESTING , NCV ; BA TCH ; ANAL YTICAL | India | United Kingdom | 0.20 | |||
30049099 | DRUG >> BEVACIZUMAB DRUG BEVACIZUMAB DRUG PRODUCT 100MG-4ML , BATCH NO. 24020010 X 0.2ML FOR LABANALYTICALTESTING , NCV ; BATC H ; LABANALYTICAL TESTING , | India | United Kingdom | 0.20 | |||
30049099 | INJECTION >> INJECTION VIAL PHARMA DRUGS&MEDI.BRYXTA 400MG INJECTIONVIAL BEVACIZUMAB B.NO.B700261 MANUFACTURING :06- 2017 EXP:05-2019 AS PER INV. ; INJECTION VIAL | India | Kenya | 25 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 400ML-16ML BEVACIREL , BATCHNO:BMV1B17002 , MANUFACTURING DT:JUN 2017 , EXP DT:MA Y 2019 ; BEVACIREL , BATCH NO:BMV1B17002 , MANUFACTURING | India | Vietnam | 100 | |||
30049044 | BEVACIZUMAB >> BEVACIZUMAB INJ 100MG-4ML 3002 BATCHNO.H0161B13 EXP:09-2018 MFD.10-2016 ; BATCH NO.H0161B13 | India | United Kingdom | 4 | |||
30043921 | BEVACIZUMAB >> BEVACIZUMAB INJ 400MG-16ML BATCH NO : H0200B12 EXP : 12-2018 , MFD : 1-2017 | India | United Kingdom | 2 | |||
30043921 | BEVACIZUMAB >> BEVACIZUMAB INJ 400MG-16ML BATCH NO : H0198B08 EXP : 09-2018 , MFD : 10-2016 | India | United Kingdom | 1 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 400 MG - 16 ML BEVACIREL , BATCH NO:BMV1B17003 , BMV1B17004 , MANUFACTURING DT:AUG2017 , OCT 2017 , EXP DT:JUN 2019 , SEP 2019 ; , B ATCH ; DT:AUG 2017 , OCT | India | Vietnam | 500 | |||
30021500 | BEVACIZUMAB >> BEVACIREL BEVACIZUMAB BEVACIREL , BEVACIZUMAB 100ML - 4ML | India | Vietnam | 1416 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 100ML-4ML BEVACIREL , BATCHNO:BMV1A17007 , MANUFACTURING DT:AUG 2017 , EXP DT:JUL 2019 ; BEVACIREL , BATCH NO:BMV1A17007 , MANUFACTURING | India | Vietnam | 1316 | |||
30049099 | INJECTION >> BEVACIZUMAB INJECTION H.L. MEDICINES- Bevataz Bevacizumab Injection 100mg VIAL ; Inj ection | India | Cameroon | 2 | |||
30049099 | BEVACIZUMAB >> AVASTIN 100MG INJ Bevacizumab 100MG inj ; in j | India | Benin | 5 | |||
30049099 | MDT >> CIZUMAB 100 E.ML OF CONCENTRATE C.25MG OF BEVACIZUMAB 4ML OF VL.C.BEVACIZUMAB100MG ETC. BNO.BA1707A MDT.08-17EDT.07-2019 ; O F ; VL.C.BEVACIZUMAB100 MG | India | United Arab Emirates | 2 | |||
30049099 | BEVACIZUMAB >> BRYXTA 400 BEVACIZUMAB 400MG- 16 ML | India | Bolivia | 1 | |||
30049099 | VIAL >> BRYXTA 100MG BEVACIZUMAB 100MG-4ML BEVACIXUMAB 1X1 VIAL ; BE VACIXUMAB | India | Mauritius | 36 | |||
30021900 | SIZE >> AVASTIN 400MG-4ML INJ. BEVACIZUMAB [PACK SIZE :16 ML ] | India | United Kingdom | 2 | |||
30049099 | BEVACIZUMAB >> BEVACIZUMAB 25 MG 4 ML | India | Singapore | 30 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 100ML-4ML BEVACIREL 100MG ,BATCH NO:BMV1A18001,, MANUFACTURING DT:JAN 2018,EXPDT:DEC 2019 QTY:28 FOC ; 100MG , BATCH ; 2018,EXP DT:DEC | India | Vietnam | 1 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 400ML-16ML BEVACIREL 400MG , BATCH NO:BMV1A18001 , , MANUFACTURING DT:JAN 2018 , EXP DT:DEC 2019 ; 400MG , BATCH ; 2018 , EX P | India | Vietnam | 690 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 100ML-4ML BEVACIREL 100MG ,BATCH NO:BMV1A18001,, MANUFACTURING DT:JAN 2018,EXPDT:DEC 2019 ; 100MG , BATCH ; 2018,EXP DT:DEC | India | Vietnam | 652 | |||
30021500 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 100 MG - 4 ML BEVACIREL 100 MG , BATCH NO:BMV1A17011 MANUFACTURING DT:NOV 2017 , EXP DT:OCT 2019 ; BEV ACIREL ; D T:NOV | India | Myanmar | 30 | |||
30049099 | BEVACIZUMAB >> BEVACIZUMAB AVASTIN BEVACIZUMAB , AVASTIN EU RMP | India | United Kingdom | 1 | |||
30049099 | FORMULATION >> FORMULATION BUFFER BEVACIZUMAB , FORMULATION BUFFER | India | United Kingdom | 20 | |||
30049099 | VIALS >> BEVACIZUMAB INTERNAL REFERENCE STANDARD 02 VIALS ; STANDARD 02 | India | Guatemala | 2 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 25 MG 4 ML | India | Singapore | 30 | |||
30043921 | EXPIRY >> MEDICINE: BEVACIZUMAB INJ 100MG-4ML BATCH NO B7227B12 EXPIRY 11-2018 MFD 12-2016 | India | United Kingdom | 2 | |||
30029090 | EXPIRY >> BEVACIZUMAB INJ 400MG-16ML B-N.H0201B15EXPIRY.01-2019 MFD.02-2017 ; B-N.H0201B15 EXPIRY.01-2019 | India | United Kingdom | 3 | |||
30043921 | EXPIRY >> PHARMA : BEVACIZUMAB INJ 100MG-4ML BATCH- B7227B12 EXPIRY- 11-2018 MFD- 12-2016 | India | United Kingdom | 3 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 400ML-16ML BEVACIREL BATCHNO.BMV1B18002 , MANUFACTURING .DT.FEB 2018 , EXP. DT. JAN.2020 ; BATCH NO.BMV1B18002 , MANUFACTURING .DT.FEB | India | Vietnam | 690 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 100ML-4ML BEVACIREL BATCHNO.BMV1A18001 , MANUFACTURING .DT. JAN 2018 , EXP. DT.DEC.2019 39 VIALS FOC NCV ; BATCH NO.BMV1A18001 , MANUFACTURING .DT. ; DT. DEC.2019 | India | Vietnam | 1 | |||
90189099 | SURGICAL >> SURGICAL INSTURMENTS SURGICAL INSTURMENTS- BEVACIZUMAB AVASTIN INJ.100MG ; AVAS TIN | India | Gambia | 2 | |||
30049056 | MEDICINES >> MEDICINES BEVATAS H.L. MEDICINES-BEVATAS BEVACIZUMAB CONCENTRATE FOR SOLUTION FOR INTRAVENOUS INFUSION 100MG VIALS ; CONC ENTRATE ; INF USION | India | Cameroon | 4 | |||
30049056 | MEDICINES >> MEDICINES BEVATAS H.L. MEDICINES-BEVATAS BEVACIZUMAB CONCENTRATE FOR SOLUTION FOR INTRAVENOUS INFUSION 100MG VIALS ; CONC ENTRATE ; INF USION | India | Cameroon | 4 | |||
30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS- ADVAMAB 400 MG/4ML INJ 1 VIAL BEVACIZUMAB | India | Saint Lucia | 17 | |||
30049099 | CIZUMAB 400 MG INJ BEVACIZUMAB BATCH NO.BB2311A MANUFACTURING DT. 07/2023 EXP. DT. 06/2025 | India | Mongolia | 65 | |||
30021290 | HARMLESS LIFE SAVING PHARMACEUTICAL MEDICINE: BEVACIZUMAB INJECTION 400MG/16ML CIZUMAB 400 SINGLE VIAL PER BOX | India | Mauritius | 10 | |||
30049099 | CIZUMAB 400 MG INJ BEVACIZUMAB BATCH NO.BB2311A MANUFACTURING DT. 07/2023 EXP. DT. 06/2025 | India | Mongolia | 65 | |||
30049099 | INDIAN HARMLESS MEDICINES - INJ CIZUMAB400 MG BEVACIZUMAB INJ 400 MG | India | Liberia | 5 | |||
30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICALS PRODUCT-CIZUMAB 100MG VIAL 1VIAL BEVACIZUMAB | India | Malawi | 12 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30049099 | CIZUMAB 400 MG INJ BEVACIZUMAB BATCH NO.BB2311A MANUFACTURING DT. 07/2023 EXP. DT. 06/2025 | India | Mongolia | 65 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30021500 | BEVACIZUMAB - INJECTIONS - 100MG - KRABEVA BATCH NO: BF22000734 | India | Maldives | 20 | |||
30049099 | DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES BEVACIZUMAB 400 MG /16ML VIAL | India | Lithuania | 8 | |||
30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - ADVAMAB 400 MG/4ML INJ 1 VIAL BEVACIZUMAB | India | British Virgin Islands | 10 | |||
30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - ADVAMAB 100 MG/4ML INJ 1 VIAL BEVACIZUMAB | India | British Virgin Islands | 18 | |||
30049099 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE BEVACIZUMAB 400MG/16ML CIZUMAB 400MG INJECTION | India | Lithuania | 4 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30049099 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE BEVACIZUMAB 400MG/16ML CIZUMAB 400MG INJECTION | India | Lithuania | 4 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30049099 | CIZUMAB 400MG INJ - BEVACIZUMAB - BATCHNO - BB2309A | India | Cameroon | 10 | |||
30049099 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE BEVACIZUMAB 400MG/16ML CIZUMAB 400MG INJECTION | India | Lithuania | 4 | |||
30049099 | CIZUMAB 400MG/16ML VIAL BEVACIZUMAB INJ 400MG 5 VIALS | India | Uganda | 5 | |||
30049099 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE BEVACIZUMAB 400MG/16ML CIZUMAB 400MG INJECTION | India | Lithuania | 4 | |||
38229090 | KRIBIOLISATM Anti Bevacizumab AVASTINELISA | India | United States | 2 | |||
30042099 | AVASTIN 100MG BEVACIZUMAB INJECTION AVASTINBATCH NO:H0350B16, MANUFACTURING DT: OCT-2022,EXP DT-SEP-2024 | India | Madagascar | 5 | |||
30049099 | CIZUMAB 400MG/16ML VIAL BEVACIZUMAB INJ 400MG 5 VIALS | India | Uganda | 5 | |||
30021500 | BRYXTA 100MG INJECTION VIAL BOLIVIA BEVACIZUMAB 1X1VIAL | India | Bolivia | 597 | |||
30021500 | HARMLESS MEDICINES INJECATABLE AND TABLETS BEVACIZUMAB 400MG INJ 1 VIAL | India | Kenya | 40 | |||
30021500 | HARMLESS MEDICINES INJECATABLE AND TABLETS BEVACIZUMAB 100MG INJ 1 VIAL | India | Kenya | 10 | |||
30049099 | BEVATAS 400 MG INJ BEVACIZUMAB | India | Burundi | 15 | |||
30049099 | CIZUMAB 400 MG INJ Bevacizumab 400mg1 VIALS | India | Sudan | 1 | |||
30049099 | CIZUMAB 400MG INJ. - BEVACIZUMAB 400MG -BATCH NO - BB2310A | India | Tanzania | 40 | |||
30049099 | CIZUMAB 400 MG INJ BEVACIZUMAB BATCH NO.BB2311A MANUFACTURING DT. 07/2023 EXP. DT. 06/2025 | India | Mongolia | 65 | |||
30021500 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE ARTICLE / ODS / PRODUCT / ITEM ARE AS FOLLOWS:KRABEVA 400MG INJ[BEVACIZUMAB INJ] 10 VIAL | India | Tanzania | 10 | |||
30021500 | BEVAMYL 25 MG/ML BEVACIZUMAB INJECTION | India | South Africa | 1000 | |||
30021500 | ABEVMY 25 MG/ML BEVACIZUMAB | India | Netherlands | 3000 | |||
30021520 | BASILIXIMAB (DCI); BEVACIZUMAB (DCI); DACLIZUMAB (DCI); ETANERCEPT (DCI); GEMTUZUMAB OZOGAMICIN (DCI); OPRELVEKIN (DCI); RITUXIMAB (DCI); TRASTUZUMAB (DCI) | India | Brazil | 5 | |||
30021520 | BASILIXIMAB (DCI); BEVACIZUMAB (DCI); DACLIZUMAB (DCI); ETANERCEPT (DCI); GEMTUZUMAB OZOGAMICIN (DCI); OPRELVEKIN (DCI); RITUXIMAB (DCI); TRASTUZUMAB (DCI) | India | Brazil | 837 | |||
29379020 | BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 37.0 MG/ML WITH BUFFER SOLUTION 24,921 LQTY:922.077 GMS | India | Russia | 922.08 | |||
30049049 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - BEVACIZUMAB 400MG INJ 1 VIAL BEVACIZUMAB | India | Seychelles | 12 | |||
29379020 | BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 36.0 MG/ML WITH BUFFER SOLUTION 23,915 LQTY:860.940 GMS | India | Russia | 860.94 | |||
30049049 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - BEVACIZUMAB 100MG INJ 1 BOTTLE BEVACIZUMAB | India | Seychelles | 12 | |||
29379020 | BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 37.0 MG/ML WITH BUFFER SOLUTION 24,921 LQTY:922.077 GMS | India | Russia | 922.08 | |||
29379020 | BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 36.0 MG/ML WITH BUFFER SOLUTION 23,915 LQTY:860.940 GMS | India | Russia | 860.94 | |||
30049099 | HARMLESS MEDICINE Cizumab 400Mg Injection Bevacizumab 400mg | India | Brazil | 10 | |||
30021500 | ABEVMY BEVACIZUMAB | India | Libya | 3000 | |||
30021500 | BEVACIZUMAB 100MG BEVACIREL 100MG | India | Dominican Republic | 100 | |||
30021500 | BRYXTA INJECTION 100MG/4ML VIAL BEVACIZUMAB 100MG BATCH NO. B300239 MANUFACTURING . DT. 05/2023 & EXP. DT. 04/2025 | India | Nepal | 20 | |||
30049099 | Avastin INJECTION-"Bevacizumab 100mg/4mlInjection" | India | Guyana | 2 | |||
30021500 | BRYXTA INJECTION 400MG/16ML VIAL BEVACIZUMAB 400MG BATCH NO. B300385 MANUFACTURING . DT.06/2023 & EXP. DT. 06/2025 | India | Nepal | 20 |
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
30049099 | INJECTION >> INJECTION BEVACIZUMAB AVASTIN 100 MG INJECTION BEVACIZUMAB | India | Seychelles | 10 | |||
30049099 | BEVACIZUMAB >> INJ AVASTIN 100 MG BEVACIZUMAB | India | Tanzania | 20 | |||
30049099 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 100MG-4ML BATCH NO: H0153B10 , EXP DT: 12-2017 MFD DT: 12-2015 ; NO : | India | United Kingdom | 20 | |||
30049099 | SOLUTION >> BEVACIZUMAB SOLUTION BEVACIZUMAB SOLUTION PACKED IN 2 BOTTLE | India | United Kingdom | 1150 | |||
30042099 | BEVACIZUMAB >> BEVACIZUMAB 25 MG 4 ML | India | United Kingdom | 25 | 60 More Columns Available | ||
30049099 | BOTTLE >> BOTTLE BEVACIZUMAB AVASTIN 4ML BOTTLE BEVACIZUMAB 100MG-4ML | India | Yemen | 10 | |||
30049099 | SIZE >> BEVACIZUMAB INJECTION 100MG-4ML. BRAND:BEVACIREL PACK SIZE: 1 VIAL OTHER MEDCNE PUTUPFOR RETAIL SALE N.E.S ; BRAND: BEVACIREL | India | Saint Kitts And Nevis | 10 | |||
30049099 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 100MG-4ML BATCH H0190B04 EXPIRY 02-2018 MFD 02-2016 | India | United Kingdom | 1 | |||
30049099 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 400MG-16ML BATCHNO H0193B25 EXP DT.05-2018 MFD DT 06-2016 ; BATCH NO | India | United Kingdom | 6 | |||
30021500 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 100MG-4ML | India | Guyana | 2 | |||
30042099 | BEVACIZUMAB >> BEVACIZUMAB 25 MG 4 ML | India | Singapore | 25 | |||
30021500 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 400MG-4ML BEVACIREL 400MG ; BEVACIR EL | India | Philippines | 2 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 100ML-4ML BEVACIREL , BATCHNO:BMV1A17007 , MANUFACTURING DT:AUG 2017 , EXP DT:JUL 2019 N.C.V. ; BEVACIREL , BATCH NO:BMV1A17007 , MANUFACTURING | India | Vietnam | 84 | |||
30049099 | DRUG >> BEVACIZUMAB DRUG BEVACIZUMAB DRUG PRODUCT 100MG-4ML , BATCH NO. 24020011 X 0.2ML FOR LAB ANALYTICAL TESTING , NCV ; BATC H ; ANALYTICA L | India | United Kingdom | 0.20 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB REFERENCE STANDARD ACTUAL QTY.: 1 CRYO TUBE | India | Nigeria | 1 | |||
30021500 | BEVACIZUMAB >> BEVACIREL BEVACIZUMAB BEVACIREL , BEVACIZUMAB 400ML-16ML QTY:400 VIAL ; QTY: 400 | India | Vietnam | 400 | |||
30021500 | BEVACIZUMAB >> BEVACIREL BEVACIZUMAB BEVACIREL , BEVACIZUMAB 100ML-4ML QTY:84 VIAL ; QTY: 84 | India | Vietnam | 84 | |||
30049099 | DRUG >> BEVACIZUMAB DRUG BEVACIZUMAB DRUG SUBSTANCE 30.0MG-ML , BATCH NO. P24-BM-0010 X 0.2ML FOR LAB ANALYTICAL TESTING , NCV ; BA TCH ; ANAL YTICAL | India | United Kingdom | 0.20 | |||
30049099 | DRUG >> BEVACIZUMAB DRUG BEVACIZUMAB DRUG PRODUCT 100MG-4ML , BATCH NO. 24020010 X 0.2ML FOR LABANALYTICALTESTING , NCV ; BATC H ; LABANALYTICAL TESTING , | India | United Kingdom | 0.20 | |||
30049099 | INJECTION >> INJECTION VIAL PHARMA DRUGS&MEDI.BRYXTA 400MG INJECTIONVIAL BEVACIZUMAB B.NO.B700261 MANUFACTURING :06- 2017 EXP:05-2019 AS PER INV. ; INJECTION VIAL | India | Kenya | 25 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 400ML-16ML BEVACIREL , BATCHNO:BMV1B17002 , MANUFACTURING DT:JUN 2017 , EXP DT:MA Y 2019 ; BEVACIREL , BATCH NO:BMV1B17002 , MANUFACTURING | India | Vietnam | 100 | |||
30049044 | BEVACIZUMAB >> BEVACIZUMAB INJ 100MG-4ML 3002 BATCHNO.H0161B13 EXP:09-2018 MFD.10-2016 ; BATCH NO.H0161B13 | India | United Kingdom | 4 | |||
30043921 | BEVACIZUMAB >> BEVACIZUMAB INJ 400MG-16ML BATCH NO : H0200B12 EXP : 12-2018 , MFD : 1-2017 | India | United Kingdom | 2 | |||
30043921 | BEVACIZUMAB >> BEVACIZUMAB INJ 400MG-16ML BATCH NO : H0198B08 EXP : 09-2018 , MFD : 10-2016 | India | United Kingdom | 1 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 400 MG - 16 ML BEVACIREL , BATCH NO:BMV1B17003 , BMV1B17004 , MANUFACTURING DT:AUG2017 , OCT 2017 , EXP DT:JUN 2019 , SEP 2019 ; , B ATCH ; DT:AUG 2017 , OCT | India | Vietnam | 500 | |||
30021500 | BEVACIZUMAB >> BEVACIREL BEVACIZUMAB BEVACIREL , BEVACIZUMAB 100ML - 4ML | India | Vietnam | 1416 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 100ML-4ML BEVACIREL , BATCHNO:BMV1A17007 , MANUFACTURING DT:AUG 2017 , EXP DT:JUL 2019 ; BEVACIREL , BATCH NO:BMV1A17007 , MANUFACTURING | India | Vietnam | 1316 | |||
30049099 | INJECTION >> BEVACIZUMAB INJECTION H.L. MEDICINES- Bevataz Bevacizumab Injection 100mg VIAL ; Inj ection | India | Cameroon | 2 | |||
30049099 | BEVACIZUMAB >> AVASTIN 100MG INJ Bevacizumab 100MG inj ; in j | India | Benin | 5 | |||
30049099 | MDT >> CIZUMAB 100 E.ML OF CONCENTRATE C.25MG OF BEVACIZUMAB 4ML OF VL.C.BEVACIZUMAB100MG ETC. BNO.BA1707A MDT.08-17EDT.07-2019 ; O F ; VL.C.BEVACIZUMAB100 MG | India | United Arab Emirates | 2 | |||
30049099 | BEVACIZUMAB >> BRYXTA 400 BEVACIZUMAB 400MG- 16 ML | India | Bolivia | 1 | |||
30049099 | VIAL >> BRYXTA 100MG BEVACIZUMAB 100MG-4ML BEVACIXUMAB 1X1 VIAL ; BE VACIXUMAB | India | Mauritius | 36 | |||
30021900 | SIZE >> AVASTIN 400MG-4ML INJ. BEVACIZUMAB [PACK SIZE :16 ML ] | India | United Kingdom | 2 | |||
30049099 | BEVACIZUMAB >> BEVACIZUMAB 25 MG 4 ML | India | Singapore | 30 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 100ML-4ML BEVACIREL 100MG ,BATCH NO:BMV1A18001,, MANUFACTURING DT:JAN 2018,EXPDT:DEC 2019 QTY:28 FOC ; 100MG , BATCH ; 2018,EXP DT:DEC | India | Vietnam | 1 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 400ML-16ML BEVACIREL 400MG , BATCH NO:BMV1A18001 , , MANUFACTURING DT:JAN 2018 , EXP DT:DEC 2019 ; 400MG , BATCH ; 2018 , EX P | India | Vietnam | 690 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 100ML-4ML BEVACIREL 100MG ,BATCH NO:BMV1A18001,, MANUFACTURING DT:JAN 2018,EXPDT:DEC 2019 ; 100MG , BATCH ; 2018,EXP DT:DEC | India | Vietnam | 652 | |||
30021500 | INJECTION >> BEVACIZUMAB INJECTION BEVACIZUMAB INJECTION 100 MG - 4 ML BEVACIREL 100 MG , BATCH NO:BMV1A17011 MANUFACTURING DT:NOV 2017 , EXP DT:OCT 2019 ; BEV ACIREL ; D T:NOV | India | Myanmar | 30 | |||
30049099 | BEVACIZUMAB >> BEVACIZUMAB AVASTIN BEVACIZUMAB , AVASTIN EU RMP | India | United Kingdom | 1 | |||
30049099 | FORMULATION >> FORMULATION BUFFER BEVACIZUMAB , FORMULATION BUFFER | India | United Kingdom | 20 | |||
30049099 | VIALS >> BEVACIZUMAB INTERNAL REFERENCE STANDARD 02 VIALS ; STANDARD 02 | India | Guatemala | 2 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 25 MG 4 ML | India | Singapore | 30 | |||
30043921 | EXPIRY >> MEDICINE: BEVACIZUMAB INJ 100MG-4ML BATCH NO B7227B12 EXPIRY 11-2018 MFD 12-2016 | India | United Kingdom | 2 | |||
30029090 | EXPIRY >> BEVACIZUMAB INJ 400MG-16ML B-N.H0201B15EXPIRY.01-2019 MFD.02-2017 ; B-N.H0201B15 EXPIRY.01-2019 | India | United Kingdom | 3 | |||
30043921 | EXPIRY >> PHARMA : BEVACIZUMAB INJ 100MG-4ML BATCH- B7227B12 EXPIRY- 11-2018 MFD- 12-2016 | India | United Kingdom | 3 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 400ML-16ML BEVACIREL BATCHNO.BMV1B18002 , MANUFACTURING .DT.FEB 2018 , EXP. DT. JAN.2020 ; BATCH NO.BMV1B18002 , MANUFACTURING .DT.FEB | India | Vietnam | 690 | |||
30021500 | BEVACIZUMAB >> BEVACIZUMAB 100ML-4ML BEVACIREL BATCHNO.BMV1A18001 , MANUFACTURING .DT. JAN 2018 , EXP. DT.DEC.2019 39 VIALS FOC NCV ; BATCH NO.BMV1A18001 , MANUFACTURING .DT. ; DT. DEC.2019 | India | Vietnam | 1 | |||
90189099 | SURGICAL >> SURGICAL INSTURMENTS SURGICAL INSTURMENTS- BEVACIZUMAB AVASTIN INJ.100MG ; AVAS TIN | India | Gambia | 2 | |||
30049056 | MEDICINES >> MEDICINES BEVATAS H.L. MEDICINES-BEVATAS BEVACIZUMAB CONCENTRATE FOR SOLUTION FOR INTRAVENOUS INFUSION 100MG VIALS ; CONC ENTRATE ; INF USION | India | Cameroon | 4 | |||
30049056 | MEDICINES >> MEDICINES BEVATAS H.L. MEDICINES-BEVATAS BEVACIZUMAB CONCENTRATE FOR SOLUTION FOR INTRAVENOUS INFUSION 100MG VIALS ; CONC ENTRATE ; INF USION | India | Cameroon | 4 | |||
30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS- ADVAMAB 400 MG/4ML INJ 1 VIAL BEVACIZUMAB | India | Saint Lucia | 17 | |||
30049099 | CIZUMAB 400 MG INJ BEVACIZUMAB BATCH NO.BB2311A MANUFACTURING DT. 07/2023 EXP. DT. 06/2025 | India | Mongolia | 65 | |||
30021290 | HARMLESS LIFE SAVING PHARMACEUTICAL MEDICINE: BEVACIZUMAB INJECTION 400MG/16ML CIZUMAB 400 SINGLE VIAL PER BOX | India | Mauritius | 10 | |||
30049099 | CIZUMAB 400 MG INJ BEVACIZUMAB BATCH NO.BB2311A MANUFACTURING DT. 07/2023 EXP. DT. 06/2025 | India | Mongolia | 65 | |||
30049099 | INDIAN HARMLESS MEDICINES - INJ CIZUMAB400 MG BEVACIZUMAB INJ 400 MG | India | Liberia | 5 | |||
30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICALS PRODUCT-CIZUMAB 100MG VIAL 1VIAL BEVACIZUMAB | India | Malawi | 12 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30049099 | CIZUMAB 400 MG INJ BEVACIZUMAB BATCH NO.BB2311A MANUFACTURING DT. 07/2023 EXP. DT. 06/2025 | India | Mongolia | 65 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30021500 | BEVACIZUMAB - INJECTIONS - 100MG - KRABEVA BATCH NO: BF22000734 | India | Maldives | 20 | |||
30049099 | DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES BEVACIZUMAB 400 MG /16ML VIAL | India | Lithuania | 8 | |||
30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - ADVAMAB 400 MG/4ML INJ 1 VIAL BEVACIZUMAB | India | British Virgin Islands | 10 | |||
30049099 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - ADVAMAB 100 MG/4ML INJ 1 VIAL BEVACIZUMAB | India | British Virgin Islands | 18 | |||
30049099 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE BEVACIZUMAB 400MG/16ML CIZUMAB 400MG INJECTION | India | Lithuania | 4 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30049099 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE BEVACIZUMAB 400MG/16ML CIZUMAB 400MG INJECTION | India | Lithuania | 4 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30049099 | BEVACIZUMAB IN-PROCESS HARVEST QTY: 50 ML | India | United Kingdom | 0.05 | |||
30049099 | CIZUMAB 400MG INJ - BEVACIZUMAB - BATCHNO - BB2309A | India | Cameroon | 10 | |||
30049099 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE BEVACIZUMAB 400MG/16ML CIZUMAB 400MG INJECTION | India | Lithuania | 4 | |||
30049099 | CIZUMAB 400MG/16ML VIAL BEVACIZUMAB INJ 400MG 5 VIALS | India | Uganda | 5 | |||
30049099 | REWARD ITEM HARMLESS PHARMACEUTICAL MEDICINES FOR HUMAN USE BEVACIZUMAB 400MG/16ML CIZUMAB 400MG INJECTION | India | Lithuania | 4 | |||
38229090 | KRIBIOLISATM Anti Bevacizumab AVASTINELISA | India | United States | 2 | |||
30042099 | AVASTIN 100MG BEVACIZUMAB INJECTION AVASTINBATCH NO:H0350B16, MANUFACTURING DT: OCT-2022,EXP DT-SEP-2024 | India | Madagascar | 5 | |||
30049099 | CIZUMAB 400MG/16ML VIAL BEVACIZUMAB INJ 400MG 5 VIALS | India | Uganda | 5 | |||
30021500 | BRYXTA 100MG INJECTION VIAL BOLIVIA BEVACIZUMAB 1X1VIAL | India | Bolivia | 597 | |||
30021500 | HARMLESS MEDICINES INJECATABLE AND TABLETS BEVACIZUMAB 400MG INJ 1 VIAL | India | Kenya | 40 | |||
30021500 | HARMLESS MEDICINES INJECATABLE AND TABLETS BEVACIZUMAB 100MG INJ 1 VIAL | India | Kenya | 10 | |||
30049099 | BEVATAS 400 MG INJ BEVACIZUMAB | India | Burundi | 15 | |||
30049099 | CIZUMAB 400 MG INJ Bevacizumab 400mg1 VIALS | India | Sudan | 1 | |||
30049099 | CIZUMAB 400MG INJ. - BEVACIZUMAB 400MG -BATCH NO - BB2310A | India | Tanzania | 40 | |||
30049099 | CIZUMAB 400 MG INJ BEVACIZUMAB BATCH NO.BB2311A MANUFACTURING DT. 07/2023 EXP. DT. 06/2025 | India | Mongolia | 65 | |||
30021500 | MEDICINES FOR CONSUMPTION AND THE DESCRIPTION OF THE ARTICLE / ODS / PRODUCT / ITEM ARE AS FOLLOWS:KRABEVA 400MG INJ[BEVACIZUMAB INJ] 10 VIAL | India | Tanzania | 10 | |||
30021500 | BEVAMYL 25 MG/ML BEVACIZUMAB INJECTION | India | South Africa | 1000 | |||
30021500 | ABEVMY 25 MG/ML BEVACIZUMAB | India | Netherlands | 3000 | |||
30021520 | BASILIXIMAB (DCI); BEVACIZUMAB (DCI); DACLIZUMAB (DCI); ETANERCEPT (DCI); GEMTUZUMAB OZOGAMICIN (DCI); OPRELVEKIN (DCI); RITUXIMAB (DCI); TRASTUZUMAB (DCI) | India | Brazil | 5 | |||
30021520 | BASILIXIMAB (DCI); BEVACIZUMAB (DCI); DACLIZUMAB (DCI); ETANERCEPT (DCI); GEMTUZUMAB OZOGAMICIN (DCI); OPRELVEKIN (DCI); RITUXIMAB (DCI); TRASTUZUMAB (DCI) | India | Brazil | 837 | |||
29379020 | BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 37.0 MG/ML WITH BUFFER SOLUTION 24,921 LQTY:922.077 GMS | India | Russia | 922.08 | |||
30049049 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - BEVACIZUMAB 400MG INJ 1 VIAL BEVACIZUMAB | India | Seychelles | 12 | |||
29379020 | BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 36.0 MG/ML WITH BUFFER SOLUTION 23,915 LQTY:860.940 GMS | India | Russia | 860.94 | |||
30049049 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - BEVACIZUMAB 100MG INJ 1 BOTTLE BEVACIZUMAB | India | Seychelles | 12 | |||
29379020 | BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 37.0 MG/ML WITH BUFFER SOLUTION 24,921 LQTY:922.077 GMS | India | Russia | 922.08 | |||
29379020 | BEVACIZUMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 36.0 MG/ML WITH BUFFER SOLUTION 23,915 LQTY:860.940 GMS | India | Russia | 860.94 | |||
30049099 | HARMLESS MEDICINE Cizumab 400Mg Injection Bevacizumab 400mg | India | Brazil | 10 | |||
30021500 | ABEVMY BEVACIZUMAB | India | Libya | 3000 | |||
30021500 | BEVACIZUMAB 100MG BEVACIREL 100MG | India | Dominican Republic | 100 | |||
30021500 | BRYXTA INJECTION 100MG/4ML VIAL BEVACIZUMAB 100MG BATCH NO. B300239 MANUFACTURING . DT. 05/2023 & EXP. DT. 04/2025 | India | Nepal | 20 | |||
30049099 | Avastin INJECTION-"Bevacizumab 100mg/4mlInjection" | India | Guyana | 2 | |||
30021500 | BRYXTA INJECTION 400MG/16ML VIAL BEVACIZUMAB 400MG BATCH NO. B300385 MANUFACTURING . DT.06/2023 & EXP. DT. 06/2025 | India | Nepal | 20 |
Volza's data of India Bevacizumab exports allows you to study detailed data with buyer supplier names for last 10 years.
Volza's data of India Bevacizumab exports helps you create a export strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
You can find India Bevacizumab export market intelligence of last 10 years with buyer, supplier, price and volume from volza.com
You can find New markets for Bevacizumab exports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
Top 5 HSN codes for Bevacizumab are HSN Code 30021500 , HSN Code 30049099 , HSN Code 30049049, HSN Code 30021290, HSN Code 30021520, You can check for details at https://www.volza.com/hs-codes.
Volza's data of India Bevacizumab exports is 100% authentic as it is based on actual export import shipments and is collected globally from over 20,000 ports from over 70+ Countries.
Data of India Bevacizumab exports contains strategic information and is very useful for exporters and importers who want to expand global trade, improve supply chain of Bevacizumab, find economical vendors, new buyers and fast growing markets.
Data of India Bevacizumab exports contains date of shipment, Name and contact details of exporter, importer, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
We update information of India Bevacizumab exports every month.
As per the Volza's India export data of Bevacizumab, Kenya accounted for maximum share with 225 shipments followed by United Kingdom with 171 and Russia at 3rd spot with 127 shipments.
You can download latest data of Dec-2023 of India Bevacizumab exports here
You can download Volza India Bevacizumab export data with names of buyers and suppliers.
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
Online |
---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
View More |
Volza Consulting |
---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
View More |
Support
Important Links
Partners
Trade Data
About Us
Partners